GSK’s Nucala has been approved in China for use as additional therapy for adults with CRSwNP.

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly’s real-time, streaming news feed keeps individual…

Read More: https://thefly.com/permalinks/entry.php/id4045155/GSK-GSKs-Nucala-approved-in-China-as-addon-therapy-for-adults-with-CRSwNP1735902495